NCT03022591

Brief Summary

This is a retrospective chart review. The purpose of this study will be to look at the outcomes of twin pregnancies diagnosed with short cervix along with the intervention (treatment) that these patients received.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2017

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

January 12, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 16, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2018

Completed
Last Updated

February 12, 2018

Status Verified

February 1, 2018

Enrollment Period

1 year

First QC Date

January 12, 2017

Last Update Submit

February 8, 2018

Conditions

Short Cervix

Outcome Measures

Primary Outcomes (1)

  • Short cervix

    management decisions and outcomes of twin pregnancies diagnosed with short cervix.

    1 year

Interventions

ManagementOTHER

management of twin pregnancies with a short cervix diagnosed between 16 0/7 WGA to 27 6/7 WGA.

Eligibility Criteria

Age14 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

14-55yrs of age Female all ethnic backgrounds

You may qualify if:

  • Charts of all women who had twins and a short cervix will be reviewed,

You may not qualify if:

  • singleton

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Therapeutics

Study Officials

  • Laure Vricella, MD

    St. Louis University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

January 12, 2017

First Posted

January 16, 2017

Study Start

January 1, 2017

Primary Completion

January 1, 2018

Study Completion

February 1, 2018

Last Updated

February 12, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share